Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GILEAD SCIENCES, INC. Director's Dealing 2017

Feb 27, 2017

29828_dirs_2017-02-27_130b8528-a788-4c58-9a10-fb1a91175210.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2017-02-23

Reporting Person: WILSON GAYLE E (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-02-23 Common Stock M 33350 $20.705 Acquired 140836 Direct
2017-02-23 Common Stock S 20365 $69.3039 Disposed 120471 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-02-23 Non-qualified Stock Option (Right to Buy) $20.705 M 33350 Disposed 2017-05-09 Common Stock (33350) Direct

Footnotes

F1: Sale prices reported for the transactions reported here range from $69.281 to $69.331. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F2: Options are 100% vested on the date of grant.